Have a feature idea you'd love to see implemented?
Let us know!

- Stocks
- Healthcare
- NASDAQ: AMGN

Price (delayed)

$319.22

Market cap

$171.59B

P/E Ratio

40.46

Dividend/share

$8.88

EPS

$7.89

Enterprise value

$222.98B

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the world's largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.

Amgen's equity has increased by 27% from the previous quarter

The revenue has grown by 21% year-on-year and by 5% since the previous quarter

AMGN's quick ratio has dropped by 67% year-on-year but it is up by 7% since the previous quarter

The net income has contracted by 44% YoY but it has grown by 35% from the previous quarter

The P/E is 71% above the 5-year quarterly average of 23.6 and 2.7% above the last 4 quarters average of 39.4

AMGN's gross margin is down by 18% year-on-year and by 4.4% since the previous quarter

What are the main financial stats of AMGN

Market
Valuations
Earnings

Shares outstanding

537.53M

Market cap

$171.59B

Enterprise value

$222.98B

Price to earnings (P/E)

40.46

Price to book (P/B)

22.79

Price to sales (P/S)

5.27

EV/EBIT

28.2

EV/EBITDA

16.54

EV/Sales

6.85

Revenue

$32.53B

EBIT

$7.91B

EBITDA

$13.48B

Free cash flow

$6.28B

Per share
Balance sheet
Liquidity

EPS

$7.89

Free cash flow per share

$11.7

Book value per share

$14.01

Revenue per share

$60.58

TBVPS

$80.64

Total assets

$90.88B

Total liabilities

$83.36B

Debt

$60.4B

Equity

$7.53B

Working capital

$6.45B

Debt to equity

8.02

Current ratio

1.32

Quick ratio

0.8

Net debt/EBITDA

3.81

Margins
Efficiency
Dividend

EBITDA margin

41.4%

Gross margin

60.5%

Net margin

13%

Operating margin

19.1%

Return on assets

4.5%

Return on equity

68.5%

Return on invested capital

10.3%

Return on capital employed

11.2%

Return on sales

24.3%

Dividend yield

2.78%

DPS

$8.88

Payout ratio

112.5%

How has the Amgen stock price performed over time

Intraday

-0.29%

1 week

0.71%

1 month

-0.34%

1 year

22.38%

YTD

10.83%

QTD

-0.93%

How have Amgen's revenue and profit performed over time

Revenue

$32.53B

Gross profit

$19.68B

Operating income

$6.22B

Net income

$4.23B

Gross margin

60.5%

Net margin

13%

The net margin has dropped by 54% year-on-year but it rose by 29% since the previous quarter

The net income has contracted by 44% YoY but it has grown by 35% from the previous quarter

The company's operating margin fell by 42% YoY and by 4.5% QoQ

AMGN's operating income is down by 30% year-on-year

What is Amgen's growth rate over time

What is Amgen stock price valuation

P/E

40.46

P/B

22.79

P/S

5.27

EV/EBIT

28.2

EV/EBITDA

16.54

EV/Sales

6.85

The P/E is 71% above the 5-year quarterly average of 23.6 and 2.7% above the last 4 quarters average of 39.4

AMGN's EPS is down by 44% year-on-year but it is up by 35% since the previous quarter

Amgen's equity has increased by 27% from the previous quarter

The stock's price to book (P/B) is 21% less than its 5-year quarterly average of 28.7 and 14% less than its last 4 quarters average of 26.6

The revenue has grown by 21% year-on-year and by 5% since the previous quarter

How efficient is Amgen business performance

AMGN's return on assets has dropped by 50% year-on-year but it is up by 32% since the previous quarter

The ROE has contracted by 47% YoY but it has grown by 36% from the previous quarter

AMGN's return on sales is down by 42% year-on-year but it is up by 11% since the previous quarter

The ROIC has contracted by 39% YoY but it has grown by 16% from the previous quarter

What is AMGN's dividend history

DPS

$8.88

Dividend yield

2.78%

Payout ratio

112.5%

Recent dividends

Special dividends are included in TTM DPS and yield

How did Amgen financials performed over time

Amgen's total assets is 9% more than its total liabilities

AMGN's quick ratio has dropped by 67% year-on-year but it is up by 7% since the previous quarter

Amgen's current ratio has plunged by 54% YoY but it has increased by 4.8% from the previous quarter

Amgen's equity has increased by 27% from the previous quarter

AMGN's debt to equity is down by 24% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.